BloodPAC
Cancer Moonshot - BloodPAC

Blog

Firm Announcements and Law Updates

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium

Published in Clinical Pharmacology and Theraputics, April 12, 2017

The cancer community understands the value of blood profiling measurements in assessing and monitoring cancer. We describe an effort among academic, government, biotechnology, diagnostic, and pharmaceutical companies called the Blood Profiling Atlas in Cancer (BloodPAC) Project. BloodPAC will aggregate, make freely available, and harmonize for further analyses, raw datasets, relevant associated clinical data (e.g., clinical diagnosis, treatment history, and outcomes), and sample preparation and handling protocols to accelerate the development of blood profiling assays.

Read More
Walt Wells
Blood Profiling Atlas in Cancer

Identifying the Mission

Thanks to remarkable scientific advances, we know that tumors shed a variety of signals into the blood, leaving behind small hints to help identify cancer type, location, and disease-stage. For this reason, researchers are especially interested in developing new ways to use this knowledge to transform how we detect and diagnose cancer, making it possible for a future wherein simple blood draws could help physicians and patients more accurately and successfully manage disease.

Read More
Walt Wells